Co‐proxamol withdrawal has reduced suicide from drugs in Scotland
Open Access
- 14 July 2008
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 66 (2) , 290-293
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Co‐proxamol is associated with excess mortality in overdose• Legislative change in 2005 has led to a phased withdrawal of co‐proxamol from the UK market WHAT THIS STUDY ADDS • Co‐proxamol legislation resulted in a marked reduction in the number of prescriptions for co‐proxamol within 6 months• This was followed by a major reduction in mortality associated with co‐proxamol poisoning• Overall mortality from drug poisoning in Scotland has also fallen over the same period, suggesting an effect on total overdose mortalityAIM: To determine what effect the withdrawal of co‐proxamol from the UK market has had on mortality from poisoning in Scotland.METHODS: This was a retrospective, observational study of mortality relating to poisoning by single agents in Scotland for the period 2000–2006. Mortality data were obtained from the General Register Office Scotland, and primary care prescribing data from the Information and Statistics Division of the Scottish Executive Health Department.RESULTS: A significant reduction in the proportion of poisoning deaths due to co‐proxamol was observed following legislation [mean 2000–2004, 37 deaths (21.8% of total poisoning deaths); 2006, 10 (7.8%); P < 0.0001]. The most significant reduction was seen in male out‐of‐hospital deaths [mean 2000–2004, 17 (21.8%); 2006, two (2.9%); P < 0.0001]. This was associated with a decline in prescriptions by 60% within 6 months of legislation. The total number of poisoning deaths also fell, slightly earlier than the full impact on co‐proxamol deaths (mean 2000–2004, 171.2; mean 2005–2006, 129.5; P = 0.005).CONCLUSIONS: Legislation has resulted in a major reduction in the number of deaths associated with co‐proxamol poisoning in Scotland, with no compensatory rise in mortality from poisonings from other common analgesics. We estimate from this study that a minimum of 300 lives across the UK will have been saved by the withdrawal of co‐proxamol.Keywords
This publication has 8 references indexed in Scilit:
- Co‐proxamol overdose is associated with a 10‐fold excess mortality compared with other paracetamol combination analgesicsBritish Journal of Clinical Pharmacology, 2005
- ECG Abnormalities in Co-proxamol (Paracetamol/Dextropropoxyphene) PoisoningClinical Toxicology, 2005
- ECG abnormalities in co-proxamol (paracetamol/dextropropoxyphene) poisoning.2005
- A multicentre study of coproxamol poisoning suicides based on coroners’ records in EnglandBritish Journal of Clinical Pharmacology, 2004
- Co-proxamol and suicideBMJ, 2003
- Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisoningsBMJ, 2003
- Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamolBMJ, 1997
- Dextropropoxyphene Deaths: Coroner's ReportHuman Toxicology, 1984